Skip to main content
Clinical Trials/NCT03490890
NCT03490890Not yet recruitingPhase 2

Microwave Ablation in Ground Glass Nodules

Shandong Provincial Hospital15 sites in 1 country200 target enrollmentStarted: May 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
200
Locations
15
Primary Endpoint
The survival of patients with GGO treated with MWA

Study Overview

Brief Summary

GGO was commonly observed recently.Radiofrequency ablation has been widely applied in the treatment of patients with GGO. No study had explored the microwave ablation in the treatment of GGO.

Detailed Description

GGO was common with the development of image. Treatments of GGO include radical surgery and irradiation. For patients who were poor candidate of surgery, image guided thermal ablation could be an alternative.Radiofrequency ablation has been widely applied in the treatment of eary-stage non small cell lung cancer and those patients with GGO. However, up to date, no study had explored the microwave ablation in the treatment of GGO.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Masking Description

All patient with GGO were treated with microwave ablation

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient has a histologically verified AIS or MIA.
  • The tumors small enough to treat (usually ≤3 cm), and without chest pleura invasion.
  • Solid cements in the GGO less than 50%.
  • No other sites of disease observed.
  • Patient is not a candidate for surgical removal of the cancer, or refused surgery.
  • Patient is not a candidate for radiation therapy, or refused radiation therapy.
  • Patient has > 6 month life expectancy.
  • Eastern Cooperative Oncology Group performance status of 0 to
  • No prior anticancer treatments including surgery, radiation,chemotherapy or local treatments.
  • Sufficient organ functions.
  • Written informed consent.

Exclusion Criteria

  • Active bacterial or fungous infection.
  • Simultaneous or metachronous (within the past 5 years) double cancers.
  • Women during pregnancy or breast-feeding.
  • Interstitial pneumonitis, pulmonary fibrosis, or severe pulmonary emphysema.
  • Uncontrollable diabetes mellitus. History of severe heart disease, heart failure, myocardial infarction within the past 6 months or attack of angina pectoris within the past 6 months.

Arms & Interventions

Microwave ablation in the GGO

Experimental

Patients with GGO were treated with microwave ablation.

Intervention: Microwave ablaton (Other)

Outcomes

Primary Outcomes

The survival of patients with GGO treated with MWA

Time Frame: From the date of randomization until the date of the date of death from any cause, assessed up to 60 months

The overall survival

Secondary Outcomes

  • The disease free survival of patients with GGO treated with MWA(From date of randomization until the date of first documented progression, assessed up to 60 months)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Xin Ye

Principal Investigator

Shandong Provincial Hospital

Study Sites (15)

Loading locations...

Similar Trials